Adultshaemophagocytic lymphohistiocytosisinduction therapyferritinefficacyBackground: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response. Objective: Our study explores the significance of serum ferritin...
The mean time of steroid application in the patients who received ruxolitinib was 28.1days. Median survival after HSCT was 64.6weeks. The adverse effects of ruxolitinib included grades 3 to 4 neutropenia ( n =7) and grades 3 to 4 thrombocytopenia ( n =6). Cytomegalovirus reactivation was ...